Otsuka ICU Medical is recalling one lot of 0.9% sodium chloride injections after a customer found a concentrated potassium ...

Patients not already receiving buprenorphine can receive the first injection of Sublocade following a single dose of transmucosal buprenorphine and a 1 hour observation period to confirm tolerability.

Otsuka ICU Medical issued a voluntary recall for one lot of 0.9% sodium chloride injection due to a potential labelling mix-up. The recall includes injections of 100 milliliter single packs to the ...

A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...